InvestorsHub Logo
Followers 45
Posts 3487
Boards Moderated 0
Alias Born 05/26/2011

Re: None

Wednesday, 12/08/2021 2:37:19 PM

Wednesday, December 08, 2021 2:37:19 PM

Post# of 118423
rgbp. As time goes by, our company will be known if its drugs, (or at least a few of them,) are known to be absolutely safe to administer, are the most efficacious, with at least 90% Treatment/Vaccine effective in all patients, which should then be RECOMMENDED by most of the doctors all over the World! Those stats will form the base from which the Company will be regarded as truly outstanding, or just another BioPharma Co., struggling to maintain its present place in the field? We have to be outstanding, not just a member of the pack who have less to offer?

Our Cancer Vaccine, (especially if it covers most of the Cancers,) seems to be our best hope to catapult ourselves onto a higher level, if it shows that our mRNA methodology doesn't come with the number of serious side-effects we are seeing today? As the After-Vaccination studies continue to mount, we will learn more about what causes them?

There is quite a bit of fear associated with medicine in general, especially with the new mRNA approach to treating Illnesses of all sorts! Those that can prove the highest safety percentage, especially a perfect one, will surge ahead of the other competitors! Efficacy is a high goal too, as that will also enter into the conclusions our Vaccines and Treatments will be regarded by the Medical establishment? The guys and scientists at the top surely focus on the safety factor, and will be interested to see the Clinical trial results, as are we! GL & a good year ahead!!